The present study demonstrated for the first time the potential antitumoractivity of IFN-α combined with the oncolytic adenovirus SG600-IL-24 inHCC both in vitro and in vivo, and suggests its furtherdevelopment as a potential candidate for HCC cancer gene therapy. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.